// App-Quantinova.ai

Mo1027 : Differences in Creatinine Between Genders Could Disadvantage Infected Cirrhotic Women: the Nacseld Experience

Researchers

Presenter

  • Florence Wong

Principal Investigators

  • Patrick S. Kamath

  • Leroy R. Thacker

  • Jasmohan S. Bajaj

  • K. Rajender Reddy

  • Heather Patton

  • Scott W. Biggins

  • Michael B. Fallon

  • Guadalupe Garcia-Tsao

  • Ram M. Subramanian

  • Benedict Maliakkal

  • Raza Malik

Medical Centers

  • University of Pennsylvania, Philadelphia, PA

  • University of Rochester Medcal Center, Rochester, NY

  • Biostatistics, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA

  • Medicine, Beth Israel Deaconess, Boston, MA

  • Medicine, Univ of Toronto, Toronto, Canada

  • University of California-San Diego, San Diego, CA

  • Family Medicine, University of Colorado, Aurora, CO

  • Internal Medicine, The University of Texas Health Science Center, Houston, TX

  • Medicine, Mayo Clinic School of Medicine, Rochester, MN

  • Baylor University Medical Center, Dallas, TX

  • Biostatistics, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA

  • Yale University School of Medicine, New Haven, CT

  • School of Medicine, Emory University, Atlanta, GA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • End-stage liver disease

  • Renal insufficiency

Biomarkers

  • Creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved